VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $842 | +216.5% | 21,995 | +102.5% | 0.00% | +100.0% |
| Q2 2023 | $266 | +5.1% | 10,862 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $253 | -8.0% | 10,862 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $275 | -99.9% | 10,862 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $209,000 | -24.5% | 10,862 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $277,000 | -0.7% | 10,862 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $279,000 | -39.7% | 10,862 | -1.8% | 0.00% | -50.0% |
| Q4 2021 | $463,000 | -3.7% | 11,059 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $481,000 | -8.0% | 11,059 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $523,000 | – | 11,059 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |